Basic Information
AffyXell Therapeutics is a joint venture established by Avacta Group and Daewoong Pharmaceutical. AffyXell Therapeutics primarily focuses on inflammation and autoimmune diseases, dedicated to developing novel mesenchymal stem cell (MSC) therapies.
AffyXell Therapeutics
Seoul,SeoulSpecialCity,SouthKorea
less than 15 people
January 01, 2020
--
--